Glycemic profile variability: An independent risk factor for diabetic neuropathy in patients with type 2 diabetes
Authors:
- Mohammad Dehghani FirouzabadiMFMohammad Dehghani Firouzabadi
- Amirhossein PoopakAPAmirhossein Poopak
- Ali SheikhyASAli Sheikhy
- Sahar SamimiSSSahar Samimi
- Pooria NakhaeiPNPooria Nakhaei
- Fatemeh MoosaieFMFatemeh Moosaie
- Soghra RabizadehSRSoghra Rabizadeh
- Manouchehr NakhjavaniMNManouchehr Nakhjavani
- Alireza EsteghamatiAEAlireza Esteghamati
- 1 December 2022
- journal article
- research article
- Published by Elsevier in Primary Care Diabetes
- Vol. 17 (1) , 38-42
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetesCardiovascular Diabetology, 2015
- Toll-like receptor 4 and tumor necrosis factor-alpha as diagnostic biomarkers for diabetic peripheral neuropathyNeuroscience Letters, 2015
- Association between HbA1c variability and mortality in patients with type 2 diabetesJournal of Diabetes and its Complications, 2014
- Diabetic neuropathy: clinical manifestations and current treatmentsThe Lancet Neurology, 2012
- Acute and chronic fluctuations in blood glucose levels can increase oxidative stress in type 2 diabetes mellitusActa Diabetologica, 2012
- Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and TreatmentsDiabetes Care, 2010
- ‘Glycaemic variability’: a new therapeutic challenge in diabetes and the critical care settingDiabetic Medicine, 2010
- Glucose Variability; Does It Matter?Endocrine Reviews, 2010
- Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCTDiabetologia, 2009
- The Relationship of Glycemic Exposure (HbA1c) to the Risk of Development and Progression of Retinopathy in the Diabetes Control and Complications TrialDiabetes, 1995